Overview

The table below summarizes the Basilea’s compounds in later stages of research.

In addition to these programs, Basilea is pursuing a number of earlier-stage projects, investigating a broad range of antibacterial and antifungal therapeutic indications.

 

PROJECT	COMPOUND CLASS	PRIMARY INDICATION
Protein synthesis inhibitors	Macrolide	Acne
Cell wall synthesis inhibitors 1	Beta-lactam	Gram-negative bacterial infections
Cell wall synthesis inhibitors 2	Beta-lactam	Gram-positive bacterial infections
DNA Synthesis	New	Broad-spectrum